Perrigo Company PLC at RBC Global Healthcare Conference (Virtual) Transcript
All right. Thanks, everybody, for joining us for our next session. I'm Randall Stanicky, the pharmaceuticals analyst here at RBC Capital Markets. And our next company presenting is Perrigo. And with us is the CEO, Murray Kessler, who is in his second year at Perrigo as CEO, and we also have Ray Silcock, who's the company's CFO. And so what I want to do is just -- first, guys, thanks for joining us. We really appreciate having you as part of our conference here.
Questions & Answers
And Murray, just to kick off, I think you can probably agree. I've not been afraid to push back on the story. And what we've been looking for, we've discussed that. But the business started to improve. You've been making changes. We've seen metrics starting to improve. And you add that to the setup as we enter the COVID-19 pandemic positioning. And we see the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |